Format

Send to

Choose Destination
Respiration. 2008;76(3):288-94. doi: 10.1159/000114246. Epub 2008 Jan 24.

Serial development of pulmonary hypertension in patients with idiopathic pulmonary fibrosis.

Author information

1
Inova Fairfax Hospital, Falls Church, VA 22042, USA. steven.nathan@inova.com

Abstract

BACKGROUND:

Idiopathic pulmonary fibrosis (IPF) is a disease with very high mortality.

OBJECTIVE:

We sought to characterize serial changes in pulmonary artery pressures (PAP) in patients with advanced IPF who survive to transplant.

METHODS:

Retrospective analysis of IPF patients comparing mean PAP at the time of initial evaluation for transplan- tation (mPAP(baseline)) with mPAP at the time of transplant (mPAP(follow-up)). The measurements were correlated with New York Heart Association (NYHA) functional class and oxygen requirements.

RESULTS:

The final cohort consisted of 44 patients with serial right heart catheterization data. The mean mPAP(baseline) and mPAP(follow-up) were 22.5 and 32.7 mm Hg, respectively. 38.6% (17/44) of the patients had pulmonary hypertension (PH) at baseline. The majority of the non-PH patients developed PH during the serial time interval with a subsequent incidence of 77.8%. At the time of transplant, 86.4% of the patients had PH. There was a significant association between transplant NYHA class, severity of PH and oxygen requirements. Transplant NYHA class IV patients had a higher rate of mPAP change. The severity of PH at the time of transplant did not affect transplant outcomes.

CONCLUSION:

PH is common and progressive in patients with advanced IPF who are transplant candidates. Serial change and severity of PAP elevations have a significant association with oxygen requirements and functional status, but not transplant outcomes. Whether or not progressive PH has a significant impact on outcomes without transplantation requires further study.

PMID:
18216461
DOI:
10.1159/000114246
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for S. Karger AG, Basel, Switzerland
Loading ...
Support Center